Dover has entered into a definitive settlement to acquire Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Image: dizain/Adobe Stock.
Malema’s products will broaden Dover’s biopharma single-use production providing, which already includes Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with amenities in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in income in the course of the full year 2022.
When เกวัดแรงดัน closes, Malema will become a part of the PSG business unit inside Dover’s Pumps & Process Solutions section.
“We see an amazing long-term growth opportunity within the bioprocessing trade driven by a powerful and growing pipeline of effective novel biologic medicine, biosimilars, protein therapies, non-COVID mRNA vaccines, as well as budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the growing adoption of more efficient single-use manufacturing processes helps a sturdy outlook for our offerings of single-use elements to end-customers. We consider that pairing Malema’s technology with our current portfolio of single-use pumps for biopharma processing will tremendously enhance the accuracy and worth proposition of our options to our clients.”
“We are methodically building out our biopharma platform via proactive capacity additions, new product growth, and opportunistic acquisitions of highly-attractive area of interest component technologies,” said Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing expertise and further strengthens our sensor portfolio with new proprietary technology. In addition to enticing biopharma applications, we count on sturdy development within the semiconductor space on the capacity expansion and re-shoring tailwinds.”
Share